Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05493618
Title Pembrolizumab, Belantamab and Dexamethasone in Refractory Multiple Myeloma.
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hackensack Meridian Health
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Lombardi Comprehensive Cancer Center, Georgetown University Washington District of Columbia 20007 United States Details
John Theurer Cancer Center, Hackensack Meridian Health Hackensack New Jersey 07410 United States Details
Jersey Shore Medical Center Neptune New Jersey 07753 United States Details
*Shaded cells indicate that there was no data available from for the field